Unlicensed varenicline Following the initial disruption to supply of varenicline (Champix) in June 2021 because of the presence of nitrosamines above the acceptable level of daily intake, Pfizer announced a wholesale and pharmacy recall of Champix in October 2021. ![]() ![]() ![]() Back to previous page | |